The impact of interferon-gamma level on the health status of patients with sickle cell disease in Basrah

Sickle cell disease (SCD) is one of the most prevalent autosomal recessive diseases, characterized by the generation of abnormal hemoglobin S. Our study aimed to assess how the serum level of interferon-gamma affects the health status of patients with SCD in Basrah. A total of 90 participants were enrolled in this study and divided into two main groups: a SCD group and a control group. The SCD group included 30 patients with SCD in steady state and 30 patients with SCD in vasoocclusive crisis; the control group included 30 ageand sexmatched apparently healthy individuals. Approval was obtained from the Research Ethics Committee of the College of Medicine, University of Basrah before conducting the study. Two milliliters of venous blood were drawn from all the participants, and ELISA tests were utilized to determine the levels of serum interferon-gamma. There was a statistically significant increase in the serum level of interferon-gamma among SCD patients (both in steady state and in crisis) compared to the control group (p = 0.05). There were no significant differences in the levels of interferon-gamma between the patients in steady state and during vaso-occlusive crisis (p > 0.05). Interferon-gamma may influence the general health of sickle cell patients and contribute to the cause of inflammation, no matter whether the patient is in stable condition or is experiencing a crisis.

1. Okongwu C.I., Fasola F.A., Adekanmi A.J., Onifade A.A. Morbidity pattern and interferon gamma level in sickle cell anemia patients with autosplenectomy. Niger J Clin Pract 2018; 21 (12): 1615–21.

2. Obeagu E.I., Muhimbura E., Kagenderezo B.P., Uwakwe O.S., Nakyeyune S., Obeagu G.U. An Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia Crisis. J Biomed Sci 2022; 11 (10): 84.

3. Conran N., Belcher J.D. Inflammation in sickle cell disease. Clin Hemorheol Microcirc 2018; 68 (2–3): 263–99.

4. Mahmoud A. Evaluation of immunological role of Interferon gamma, Interleukin-10 and CD4+ T lym- phocytes in pediatric patients with sickle cell disease. Al-Azhar University Journal of Virus Researches and Studies 2020; 2(1): 1–15.

5. Pathare A., Al Kindi S., Alnaqdy A.A., Daar S., Knox-Macaulay H., Dennison D. Cytokine profile of sickle cell disease in Oman. Am J Hematol 2004; 77 (4): 323–8.

6. Aliu R., Iliya J., Quadri O.R., Ibrahim O.R., Daniel E. Haematological Profile of Children With Sickle Cell Anaemia in Steady State. Cureus 2020; 12 (10): e11011.

7. Mah A.Y., Cooper M.A. Metabolic Regulation of Natural Killer Cell IFN-g Production. Crit Rev Immunol 2016; 36 (2): 131–47.

8. Khalifa A.M., Albeladi B.M., Amin H.A., Johari N.M., Alosaimi R.S., Hamdi W.A., et al. Role of interferon gamma in the pathogenesis of sickle cell crisis. UPI J Pharm Med Health Sci 2018; 1 (2): JPMHS13.

9. Nnodim J., Meludu S.C., Dioka C.E., Martin I., Ukaibe N., Ihim A. Cytokine expression in homozygous SCA. Journal of Krishna Institute of Medical Science University 2015; 4 (1): 34–7.

10. Musa B.O.P., Onyemelukwe G.C., Hambolu J.O., Mamman A.I., Albarka H.I. Pattern of serum cytokine expression and T-cell subsets in Sickle Cell Disease patients in vaso-occlusive crisis. Clin Vaccine Immunol 2010; 17 (4): 602–8. DOI: 10.1128/CVI.00145-09